Mairs & Power’s Northwest Biotherapeutics NWBO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-12,500
Closed -$2K – 210
2020
Q1
$2K Hold
12,500
– – ﹤0.01% 198
2019
Q4
$3K Hold
12,500
– – ﹤0.01% 220
2019
Q3
$3K Hold
12,500
– – ﹤0.01% 214
2019
Q2
$3K Hold
12,500
– – ﹤0.01% 217
2019
Q1
$3K Hold
12,500
– – ﹤0.01% 212
2018
Q4
$3K Hold
12,500
– – ﹤0.01% 200
2018
Q3
$2K Hold
12,500
– – ﹤0.01% 216
2018
Q2
$3K Hold
12,500
– – ﹤0.01% 213
2018
Q1
$3K Hold
12,500
– – ﹤0.01% 202
2017
Q4
$3K Hold
12,500
– – ﹤0.01% 198
2017
Q3
$2K Hold
12,500
– – ﹤0.01% 200
2017
Q2
$2K Hold
12,500
– – ﹤0.01% 198
2017
Q1
$3K Hold
12,500
– – ﹤0.01% 202
2016
Q4
$4K Hold
12,500
– – ﹤0.01% 188
2016
Q3
$7K Hold
12,500
– – ﹤0.01% 193
2016
Q2
$7K Hold
12,500
– – ﹤0.01% 188
2016
Q1
$18K Hold
12,500
– – ﹤0.01% 187
2015
Q4
$40K Buy
+12,500
New +$60.1K ﹤0.01% 188

Other funds holding NWBO

Mairs & Power's NWBO Position: Q2 2020 in Review

Mairs & Power sold out of Northwest Biotherapeutics (NWBO) in Q2 2020, closing a stake of 12,500 shares — an estimated $2K sold.

Mairs & Power first reported a position in NWBO in Q4 2015 and held it in 18 quarters. The position peaked at $40K in Q4 2015. 5 funds tracked by Wall St. Rank hold NWBO as of Q2 2020.

  • Mairs & Power reported no remaining Northwest Biotherapeutics position as of Q2 2020 after selling out during the quarter.
  • Mairs & Power sold 12,500 Northwest Biotherapeutics shares in Q2 2020, an estimated $2K.
  • Mairs & Power first reported a position in Northwest Biotherapeutics in Q4 2015 and held it in 18 quarters.
  • Mairs & Power's Northwest Biotherapeutics position peaked at $40K in Q4 2015.
  • 5 funds tracked by Wall St. Rank held Northwest Biotherapeutics as of Q2 2020.

Based on Mairs & Power's 13F filing for Q2 2020, filed 14 Aug 2020.